Related Experiment Video
Updated: Apr 27, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Our 2014 approach to breakthrough invasive fungal infections
Georg Maschmeyer1, Thomas F Patterson
1Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of the Charité University Medicine of Berlin, Potsdam, Germany.
Abstract:
Evidence-based clinical pathways to direct antifungal treatment options in patients with breakthrough fungal infections during current systemic antifungal therapy are not available. Nonetheless, for defined settings of such breakthrough infections approaches to management can be recommended based on clinical, epidemiological, pharmacological and in vitro susceptibility data.
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Antifungal Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota

